ERBB2 and neoplasm: The eighth edition of the AJCC pathological prognostic staging (PPS) integrates the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor-2 (HER2), and tumor grade into AS, which facilitates better precise prognostic stratification than AS [8-10].